CVS HEALTH CORPORATION earnings per share and revenue
On Feb 10, 2026, CVS reported earnings of 1.09 USD per share (EPS) for Q4 25, beating the estimate of 1.00 USD, resulting in a 8.80% surprise. Revenue reached 105.69 billion, compared to an expected 104.63 billion, with a 1.02% difference. The market reacted with a -0.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 20 analysts forecast an EPS of 2.25 USD, with revenue projected to reach 96.08 billion USD, implying an increase of 106.42% EPS, and decrease of -9.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were CVS HEALTH CORPORATION's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, CVS HEALTH CORPORATION reported EPS of $1.09, beating estimates by 8.8%, and revenue of $105.69B, 1.02% above expectations.
How did the market react to CVS HEALTH CORPORATION's Q4 2025 earnings?
The stock price moved down -0.09%, changed from $75.77 before the earnings release to $75.70 the day after.
When is CVS HEALTH CORPORATION expected to report next?
The next earning report is scheduled for Apr 29, 2026.
What are the forecasts for CVS HEALTH CORPORATION's next earnings report?
Based on 20
analysts, CVS HEALTH CORPORATION is expected to report EPS of $2.25 and revenue of $96.08B for Q1 2026.